What is the starting dose of Jardiance (empagliflozin) for an adult patient with type 2 diabetes and normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Jardiance Starting Dose

The recommended starting dose of Jardiance (empagliflozin) is 10 mg once daily, taken in the morning, with or without food. 1

Dosing Algorithm

Initial dose: Start with 10 mg once daily for all adult patients with type 2 diabetes and adequate renal function 2, 1

Dose titration: The dose may be increased to 25 mg once daily if additional glycemic control is needed, though this higher dose provides no additional cardiovascular or renal benefit beyond the 10 mg dose 1

Critical Pre-Treatment Renal Assessment

Before initiating Jardiance, you must assess renal function 1:

  • Do not start Jardiance if eGFR is below 45 mL/min/1.73 m² 2, 1
  • Discontinue if eGFR falls persistently below 45 mL/min/1.73 m² during treatment 1
  • The glucose-lowering efficacy decreases with declining renal function, though cardiovascular and kidney benefits are preserved at lower eGFR levels 3

Rationale for 10 mg Starting Dose

The 10 mg dose is specifically recommended because it was the lowest dose tested in cardiovascular and renal outcomes trials (EMPA-REG OUTCOME), and there is no evidence of a graded dose-response relationship for cardiovascular or renal protection. 2 This means starting at 10 mg provides full cardiovascular and renal benefits without requiring titration for these outcomes 2

Key Safety Precautions When Initiating

Concomitant medication adjustments: 2

  • If HbA1c is well-controlled at baseline or the patient has frequent hypoglycemic events, reduce or stop sulfonylureas/glinides
  • Consider reducing total daily insulin dose by approximately 20% when starting Jardiance

Volume status considerations: 2

  • May cause intravascular volume contraction
  • Consider stopping or reducing diuretic dose if applicable

Surgical planning: 2, 3, 4

  • Discontinue at least 3 days before planned surgery to prevent postoperative ketoacidosis

Common Adverse Effects to Monitor

  • Genital mycotic infections occur in approximately 6% of patients (versus 1% on placebo), more common in women 3, 4
  • Urinary tract infections may occur 3, 4
  • Euglycemic diabetic ketoacidosis risk is increased, especially in insulin-requiring patients 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Empagliflozin Therapy for Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Empagliflozin Dosing and Monitoring for Adults with Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.